133 related articles for article (PubMed ID: 23775136)
1. C332C genotype of glyoxalase 1 and its association with late diabetic complications.
Groener JB; Reismann P; Fleming T; Kalscheuer H; Lehnhoff D; Hamann A; Roser P; Bierhaus A; Nawroth PP; Rudofsky G
Exp Clin Endocrinol Diabetes; 2013 Jul; 121(7):436-9. PubMed ID: 23775136
[TBL] [Abstract][Full Text] [Related]
2. No association of the 94T/G polymorphism in the adiponectin gene with diabetic complications.
Rudofsky G; Schlimme M; Schlotterer A; von Eynatten M; Reismann P; Tafel J; Grafe I; Morcos M; Nawroth P; Bierhaus A; Hamann A
Diabetes Obes Metab; 2005 Jul; 7(4):455-9. PubMed ID: 15955133
[TBL] [Abstract][Full Text] [Related]
3. Identification of glyoxalase 1 polymorphisms associated with enzyme activity.
Peculis R; Konrade I; Skapare E; Fridmanis D; Nikitina-Zake L; Lejnieks A; Pirags V; Dambrova M; Klovins J
Gene; 2013 Feb; 515(1):140-3. PubMed ID: 23201419
[TBL] [Abstract][Full Text] [Related]
4. The GLO1 C332 (Ala111) allele confers autism vulnerability: family-based genetic association and functional correlates.
Gabriele S; Lombardi F; Sacco R; Napolioni V; Altieri L; Tirindelli MC; Gregorj C; Bravaccio C; Rousseau F; Persico AM
J Psychiatr Res; 2014 Dec; 59():108-16. PubMed ID: 25201284
[TBL] [Abstract][Full Text] [Related]
5. Fructosamine 3-kinase and glyoxalase I polymorphisms and their association with soluble RAGE and adhesion molecules in diabetes.
Škrha J; Muravská A; Flekač M; Horová E; Novák J; Novotný A; Prázný M; Škrha J; Kvasnička J; Landová L; Jáchymová M; Zima T; Kalousová M
Physiol Res; 2014; 63(Suppl 2):S283-91. PubMed ID: 24908234
[TBL] [Abstract][Full Text] [Related]
6. Association of two glyoxalase I gene polymorphisms with nephropathy and retinopathy in Type 2 diabetes.
Wu JC; Li XH; Peng YD; Wang JB; Tang JF; Wang YF
J Endocrinol Invest; 2011 Nov; 34(10):e343-8. PubMed ID: 21738003
[TBL] [Abstract][Full Text] [Related]
7. [Participation of glyoxalases and methylglyoxal in diabetic complication development].
Piskorska D; Kopieczna-Grzebieniak E
Pol Merkur Lekarski; 1998 Jun; 4(24):342-4. PubMed ID: 9771022
[TBL] [Abstract][Full Text] [Related]
8. A M55V polymorphism in the SUMO4 gene is associated with a reduced prevalence of diabetic retinopathy in patients with Type 1 diabetes.
Rudofsky G; Schlotterer A; Humpert PM; Tafel J; Morcos M; Nawroth PP; Bierhaus A; Hamann A
Exp Clin Endocrinol Diabetes; 2008 Jan; 116(1):14-7. PubMed ID: 17926234
[TBL] [Abstract][Full Text] [Related]
9. Polymorphisms in glyoxalase 1 gene are not associated with vascular complications: the Hoorn and CoDAM studies.
Engelen L; Ferreira I; Brouwers O; Henry RM; Dekker JM; Nijpels G; Heine RJ; van Greevenbroek MM; van der Kallen CJ; Blaak EE; Feskens EJ; ten Cate H; Stehouwer CD; Schalkwijk CG
J Hypertens; 2009 Jul; 27(7):1399-403. PubMed ID: 19412133
[TBL] [Abstract][Full Text] [Related]
10. Common polymorphism in the cannabinoid type 1 receptor gene (CNR1) is associated with microvascular complications in type 2 diabetes.
Buraczynska M; Wacinski P; Zukowski P; Dragan M; Ksiazek A
J Diabetes Complications; 2014; 28(1):35-9. PubMed ID: 24075694
[TBL] [Abstract][Full Text] [Related]
11. [Relationship between I/D polymorphism of angiotensin I converting enzyme gene and microvascular complications in type 2 diabetic patients].
Moleda P; Majkowska L; Safranow K; Adler G; Goracy I
Przegl Lek; 2007; 64(3):134-9. PubMed ID: 17941464
[TBL] [Abstract][Full Text] [Related]
12. Glyoxalase 1 enzyme activity in erythrocytes and Ala111Glu polymorphism in type 1-diabetes patients.
Sakhi AK; Berg JP; Berg TJ
Scand J Clin Lab Invest; 2013 Mar; 73(2):175-81. PubMed ID: 23360186
[TBL] [Abstract][Full Text] [Related]
13. Association of LMNA 1908C/T polymorphism with cerebral vascular disease and diabetic nephropathy in Japanese men with type 2 diabetes.
Liang H; Murase Y; Katuta Y; Asano A; Kobayashi J; Mabuchi H
Clin Endocrinol (Oxf); 2005 Sep; 63(3):317-22. PubMed ID: 16117820
[TBL] [Abstract][Full Text] [Related]
14. Association between
Zeng Q; Yang T; Wei W; Zou D; Wei Y; Han F; He J; Huang J; Guo R
Front Endocrinol (Lausanne); 2023; 14():1235581. PubMed ID: 38027126
[TBL] [Abstract][Full Text] [Related]
15. A419C (E111A) polymorphism of the glyoxalase I gene and vascular complications in chronic hemodialysis patients.
Kalousová M; Germanová A; Jáchymová M; Mestek O; Tesar V; Zima T
Ann N Y Acad Sci; 2008 Apr; 1126():268-71. PubMed ID: 18079478
[TBL] [Abstract][Full Text] [Related]
16. The human red blood cell glyoxalase system in diabetes mellitus.
Thornalley PJ; Hooper NI; Jennings PE; Florkowski CM; Jones AF; Lunec J; Barnett AH
Diabetes Res Clin Pract; 1989 Aug; 7(2):115-20. PubMed ID: 2776650
[TBL] [Abstract][Full Text] [Related]
17. The genetic polymorphisms and activity of glyoxalase 1 as a risk factor for acute coronary syndrome in South Indians with type 2 diabetes mellitus.
Bora S; Adole PS; Vinod KV; Pillai AA; Ahmed S
Gene; 2023 Nov; 885():147701. PubMed ID: 37572800
[TBL] [Abstract][Full Text] [Related]
18. Glyoxalase in diabetes, obesity and related disorders.
Rabbani N; Thornalley PJ
Semin Cell Dev Biol; 2011 May; 22(3):309-17. PubMed ID: 21335095
[TBL] [Abstract][Full Text] [Related]
19. Glyoxalase-1 overexpression in bone marrow cells reverses defective neovascularization in STZ-induced diabetic mice.
Vulesevic B; McNeill B; Geoffrion M; Kuraitis D; McBane JE; Lochhead M; Vanderhyden BC; Korbutt GS; Milne RW; Suuronen EJ
Cardiovasc Res; 2014 Feb; 101(2):306-16. PubMed ID: 24259499
[TBL] [Abstract][Full Text] [Related]
20. The -174G>C IL-6 gene promoter polymorphism and diabetic microvascular complications.
Rudofsky G; Schlotterer A; Reismann P; Engel J; Grafe IA; Tafel J; Morcos M; Humpert PM; Nawroth P; Bierhaus A; Hamann A
Horm Metab Res; 2009 Apr; 41(4):308-13. PubMed ID: 19140096
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
